Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease

This publication has 18 references indexed in Scilit:

• Autoantibodies Activating Human β ₁ -Adrenergic Receptors Are Associated With Reduced Cardiac Function in Chronic Heart Failure
  Circulation, 1999
• Probing human β1- and β2-adrenoceptors with domain-specific fusion protein antibodies
  European Journal of Pharmacology, 1996
• Autoantibodies against Cardiac G-Protein-Coupled Receptors Define Different Populations with Cardiomyopathies but Not with Hypertension
  Clinical Immunology and Immunopathology, 1994
• Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect.
  Circulation, 1994
• Assessment of immune modulation of β-adrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factors
  American Heart Journal, 1992
• Purification and functional characterization of the human β₂‐adrenergic receptor produced in baculovirus‐infected insect cells
  FEBS Letters, 1991
• Dot immunobinding and immunoblotting of picogram and nanogram quantities of small peptides on activated nitrocellulose
  Journal of Immunological Methods, 1990
• Cloning of the cDNA for the human beta 1-adrenergic receptor.
  Proceedings of the National Academy of Sciences, 1987
• cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.
  Proceedings of the National Academy of Sciences, 1987
• Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins
  Journal of Immunological Methods, 1984